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Abstract
Background: Lyme disease is a common vector-borne disease caused by the spirochete Borrelia burgdorferi (Bb), which
manifests as systemic and targeted tissue inflammation. Both in vitro and in vivo studies have shown that Bb-induced
inflammation is primarily host-mediated, via cytokine or chemokine production that promotes leukocyte adhesion/
migration. Whether Bb produces mediators that can directly alter the vascular permeability in vivo has not been
investigated. The objective of the present study was to investigate if Bb produces a mediator(s) that can directly activate
endothelial cells resulting in increases in permeability in intact microvessels in the absence of blood cells.
Methodology/Principal Findings: The effects of cell-free, spent culture medium from virulent (B31-A3) and avirulent (B31-A)
B. burgdorferi on microvessel permeability and endothelial calcium concentration, [Ca
2+]i, were examined in individually
perfused rat mesenteric venules. Microvessel permeability was determined by measuring hydraulic conductivity (Lp).
Endothelial [Ca
2+]i, a necessary signal initiating hyperpermeability, was measured in Fura-2 loaded microvessels. B31-A3
spent medium caused a rapid and transient increase in Lp and endothelial [Ca
2+]i. Within 2–5 min, the mean peak Lp
increased to 5.660.9 times the control, and endothelial [Ca
2+]i increased from 113611 nM to a mean peak value of
324635 nM. In contrast, neither endothelial [Ca
2+]i nor Lp was altered by B31-A spent medium.
Conclusions/Significance: A mediator(s) produced by virulent Bb under culture conditions directly activates endothelial
cells, resulting in increases in microvessel permeability. Most importantly, the production of this mediator is associated with
Bb virulence and is likely produced by one or more of the 8 plasmid(s) missing from strain B31-A.
Citation: Zhou X, Miller MR, Motaleb M, Charon NW, He P (2008) Spent Culture Medium from Virulent Borrelia burgdorferi Increases Permeability of Individually
Perfused Microvessels of Rat Mesentery. PLoS ONE 3(12): e4101. doi:10.1371/journal.pone.0004101
Editor: Malcolm James Horsburgh, University of Liverpool, United Kingdom
Received September 23, 2008; Accepted November 26, 2008; Published December 31, 2008
Copyright:  2008 Zhou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Heart, Lung and Blood Institute grants HL56237 and HL084338 (P. He), Allergy and Infectious Diseases Institute
grant AI29743 (N. W. Charon) and American Heart Association grant 0755614B (M. R. Miller). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: phe@hsc.wvu.edu
Introduction
Lyme disease, caused by the spirochete Borrelia burgdorferi (Bb),i s
the most common vector-borne disease in the US and Europe [1].
When infected Ixodes ticks feed on humans, the spirochetes move
from the tick into the skin, and as the spirochetes move through
the dermis, they often cause fever, skin rash (erythra migrans), and
flu-like symptoms [2]. Within several days, Bb penetrates the
vascular system and is disseminated to other tissues, inducing
arthritis, cardiac complications, and neurological symptoms [1,3].
The use of antibiotics usually reduces antibody titers, indicating a
direct role of Bb in the manifestations of Lyme disease [3].
Fostered by environmental conditions, Lyme disease is predicted
to be ‘‘a continuing public health concern’’ [3]. A better
understanding of the mechanisms of Bb-induced inflammation
and the factors that facilitate Bb penetration through vascular walls
may benefit prevention of disease progression.
Bb-induced inflammation has been studied in vitro, by co-
culturing Bb with endothelial monolayers and/or leukocytes, with
a focus on proinflammatory cytokines, chemokines and other
molecules produced by host cells that promote inflammation and
leukocyte adhesion/migration [4–6]. Studies in vivo indicate the
innate immune response plays a significant role in Bb-mediated
inflammation (reviewed in [7,8]). Some Bb lipoproteins interact
with Toll-like receptors (TLR) in the innate immune response [9–
12]. However, additional mechanisms may also contribute to Bb-
mediated inflammation [12–14]. Few studies have examined the
possibility that Bb may produce a mediator(s) that directly causes
inflammation. Bb does not synthesize the classic LPS [15–18].
Although two Bb glycolipids have been identified, with some
properties similar to LPS [18], it is not known if these glycolipids
mediate inflammatory reactions. In vitro,aBb lipoprotein has been
shown to upregulate expression of endothelial cell E-selectin,
VCAM-1, ICAM-1 and neutrophil migration [19]. Whether Bb
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permeability of intact vascular walls has not been investigated.
Studies conducted in individually perfused microvessels demon-
strated that, in addition to inflammation mediated by leukocyte/
endothelial cell interactions, endothelial cells can be directly
activated by a variety of mediators, resulting in a rapid increase in
microvessel permeability that is initiated by increases in endothe-
lial [Ca
2+]i [20,21]. If Bb produces a mediator(s) that can directly
activate endothelial cells lining microvessel walls, it would not only
cause leakage of excessive fluid and macromolecules, but the
resulting barrier dysfunction may also facilitate Bb penetration and
dissemination to targeted tissues. In addition, some of the 21
circular and linear plasmids (cp and lp, respectively) in Bb [16] are
associated with infectivity, especially lp25, lp28-1, lp26 and cp26;
presumably they encode virulence factors important in the
pathogenesis of Lyme disease [22–25]. The extent to which Bb
plasmids may be associated with Bb-induced inflammation in vivo
remains unknown.
The objective of the present study was to investigate if Bb
produces a mediator(s) that can directly increase permeability in
intact microvessels. Cell-free, spent Bb culture medium was used to
perfuse individually cannulated rat mesenteric venules. The
changes in microvessel permeability were determined by measur-
ing hydraulic conductivity (Lp) before and after each vessel was
exposed to Bb spent medium, and associated changes in
endothelial [Ca
2+]i were measured in Fura-2 loaded microvessels
[26]. To investigate whether Bb-induced inflammation is associ-
ated with virulence, the effects of spent medium from both virulent
(B31-A3) and avirulent (B31-A) strains on microvessel Lp and
endothelial [Ca
2+]i were investigated. The plasmid content of
strains B31-A3 and B31-A were determined by PCR analysis.
Materials and Methods
Bb strains and culture
Bb strains B31-A3 and B31-A were cultured in Barbour-
Stonner-Kelly II medium containing 6% rabbit serum (BSK-II) at
33uC in a humidified chamber with 3% CO2. B31-A3, a low-
passage, virulent, cloned strain derived from B3 MI that contains
20 circular and linear plasmids [22], was the generous gift from
Dr. P. Rosa, Rocky Mountain Laboratories, and was propagated
in culture for no more than 3 passages. B31-A is a cloned, high-
passage, avirulent strain derived from B31 MI [27] that has lost
multiple plasmids; the plasmid content of this strain is presented in
this study. Cells were enumerated by flow cytometry [28]. B31-A3
and B31-A strains grew at similar rates, and spent medium was
prepared when strains were at comparable cell densities.
Spent-medium preparation
Both strains B31-A3 and B31-A were inoculated into BSK-II
medium at low cell density and grown to late log/early plateau
phase (,1–3610
8 cells/ml); .95% of the cells were highly motile.
Cells were removed and spent medium was prepared by
centrifuging aliquots of cultures at ,14,0006g for 8 min at room
temperature and filtering supernatants through 0.1 mm filters into
sterile plastic tubes. No cell growth was detected when filtered,
spent medium was placed in an incubator for a month. The pH of
spent medium was adjusted to 7.4–7.45, and the protein
concentration of the medium was measured immediately before
Lp measurements in individually perfused mesenteric venules,
using a refractometer. BSK-II medium not inoculated with
spirochetes but subject to the same incubation and filtering
procedures as active cultures served as medium controls.
PCR analysis of Bb plasmids
PCR was used to identify the plasmids retained in B31-A and
B31-A3 strains. The PCR conditions were described previously
[22], and used 50 ml of total reaction volume, GoTaq polymerase
(Promega), and unique primer sets for the 21 different linear and
circular plasmids; primer sequence information was generously
provided by D. R. Akins, Oklahoma University, Oklahoma City,
OK. PCR products were resolved by agarose gel electrophoresis
and visualized by ethidium bromide staining.
Animal Preparation
Experiments were carried out on Female Sprague-Dawley rats
(2–3 mo old, 220 to 250 g, Hilltop Laboratory Animal, Scottdale,
PA) anesthetized with pentobarbital sodium (65 mg/kg.body wt)
given subcutaneously. Additional 3 mg doses were given as needed
to maintain anesthesia. All procedures and animals used were
approved by the Animal Care and Use Committee at West
Virginia University, in compliance with all relevant federal
guidelines and institutional policies. Each rat was anesthetized,
then the trachea was intubated, and a midline surgical incision (1.5
to 2 cm) was made in the abdominal wall. The mesentery was
gently taken out from the abdominal cavity and spread over a
pillar for measurements of Lp or over a glass coverslip attached to
an animal tray for measuring endothelial [Ca
2+]i. The upper
surface of the mesentery was continuously superfused with
mammalian Ringer solution at 37uC. All experiments were carried
out in venular microvessels with diameters ranging between 35
and 50 mm, with one experiment per microvessel in each animal.
Measurement of hydraulic conductivity (Lp)
All measurements were based on the modified Landis technique
thatmeasureswaterfluxacrossthemicrovesselwall.Theassumptions
and limitations of the original method and its application in
mammalian microvesselshave been evaluated elsewhere [29]. Briefly,
a single venular microvessel was cannulated with a glass micropipette
filled with albumin-Ringer solution (control) containing 1% (v/v)
hamster red blood cells as markers. The micropipette was connected
to a water manometer. A hydrostatic pressure (range 30–70 cmH2O)
was applied through the micropipette to the microvessel lumen to
allow continuous flow of perfusate in the vessel. A CCD camera was
connected to the microscope, and video images were continuously
recorded from a segment of the perfused microvesselthroughout each
experiment for data analysis. For each measurement, the perfused
vessel was occluded downstream with a glass rod for 5–7 sec and then
the rod was released to allow perfusate flow for at least 15 sec before
another occlusion was made. The initial water flow per unit area of
microvessel wall [(Jv/S)0, where Jv is water flux and S is unit area of
the microvessel wall] was calculated from the velocity of the marker
cell after the vessel was occluded, the vessel radius, and the length
between the marker cell position and the occlusion site (Fig. 1).
M i c r o v e s s e lL pw a sc a l c u l a t e df r o mt h eS t a r l i n ge q u a t i o n ,L p=( J v /
S)0,/ DP, where DP is the pressure difference between the hydrostatic
pressure applied to the microvessel and the effective oncotic pressure
generated from protein in the perfusate. The effective oncotic
pressure with bovine serum albumin at 10 mg/ml is 3.6 cmH2Oa n d
at 50 mg/ml is 21 cmH2O[ 3 0 ] .T h eo n c o t i cp r e s s u r e si nB S KI I
medium and B. burgdorferi spent medium were estimated accordingly,
based on their measured protein concentrations ranging from 45–
55 mg/ml.
Measurements of endothelial [Ca2+]i
Endothelial cell [Ca
2+]i was measured in individually perfused
microvessels using the fluorescent Ca
2+ indicator fura 2-AM, as
B.burgdorferi and Permeability
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Diaphod 300 microscope equipped with a Nikon photometry
system, computer-controlled shutter, and filter changer (Lambda
10-2; Sutter Instrument; Novato, CA). Briefly, a venular
microvessel in rat mesentery was cannulated and perfused first
with albumin-Ringer solution containing 10 mM fura 2-AM for
45 min. The vessel was then recannulated and perfused with
albumin-Ringer solution for 10 min to remove fura 2-AM from
the lumen. Fluorescence intensity was collected by a Nikon Fluor
lens (620, NA 0.75) through a rectangular diaphragm of the
photometer (,150650 mm) (Fig. 2). The excitation wavelengths
for fura 2-AM were selected by two narrow-band interference
filters (34065 and 38065 nm; Oriel) from a Xenon (75 W) light
source, and the emission was separated with a dichroic mirror
(DM400) and a wide-band interference filter (500635 nm; Oriel).
The excitation wavelength alternated between 340 and 380 nm,
and corresponding FI values (FI340 and FI380, respectively) were
collected with a 0.25-s exposure at each wavelength. At the end of
each experiment, the microvessel was superfused with a modified
Ringer solution (5 mM Mn
2+ without Ca
2+) while being perfused
with the same solution containing ionomycin (10 mM) to bleach
the Ca
2+-sensitive form of fura 2. The background FIs due to
unconverted fura 2-AM and other Ca
2+-insensitive forms of fura 2
were subtracted from FI340 and FI380 values. The ratios of the two
FI values were converted to Ca
2+ concentrations using an in vitro
calibration curve [20].
Data analysis and statistics
PCR analysis of plasmid contents for B31-A3 and B31-A strains
were repeated three times to assure reproducibility. The Lp
changes of each vessel after exposure to testing solutions were
expressed as Lptest/Lpcontrol. Values are expressed as means6SE.
If Lp is relatively constant throughout the time course, the mean
Lp value for each perfusate was calculated from all of the
occlusions during that perfusion period. If a transient increase in
Lp is observed, Lp is reported as the means of peak values. For
statistical comparisons, a paired t-test was used for the mean values
obtained before and after stimulation from the same vessel. An
unpaired t-test and one way ANOVA were used to compare mean
values among groups. A probability value of P,0.05 was
considered statistically significant. In summary figures, * indicates
a significant increase from the negative control, and { indicates
significantly lower than the positive control.
Results
Plasmid profiles of B31-A3 and B31-A
PCR analysis demonstrated that our B31-A strain has lost eight
plasmids (lp5, lp21, lp25, lp28-1, lp28-4, cp32-6, cp32-7 and lp36)
retained in B31-A3 and confirms that strain B31-A3 retains all
plasmids associated with the original virulent B31 MI isolate
except cp9 [22] (Fig. 3). Thus, a major difference between these
two strains is their plasmid content.
Figure 1. Hydraulic conductivity, Lp, was measured based on
the modified Landis technique in individually perfused
microvessels. Jv is the initial water flow per unit area of microvessel
wall (S), which was calculated from the velocity of the marker cell (Vcell)
after the vessel was occluded, the vessel radius (r), and the length
between the marker cell position and the occlusion site (L).
doi:10.1371/journal.pone.0004101.g001
Figure 2. Measurements of changes in endothelial [Ca
2+]i in an
individually perfused microvessel. The vessel was first perfused
with albumin-Ringer solution containing Fura 2-AM for 45 min to load
the endothelial cells of the microvessel wall. The vessel was then
recannulated and perfused with albumin-Ringer solution for 10 min to
remove fura 2-AM from the vessel lumen. Fluorescence intensity was
collected through a rectangular diaphragm of the photometer (yellow
area) under control conditions and after exposure to testing solutions.
doi:10.1371/journal.pone.0004101.g002
Figure 3. PCR analysis of plasmids in strains B31-A and B31-A3. Twenty-one pairs of specific primers were used to amplify all the circular and
linear plasmids contained in the two strains. DNA markers (left lane) identify the sizes of amplified DNAs. ‘‘*’’ indicates the plasmids that are lost from
B31-A strain. A) B31-A is missing lp25, lp28-1, lp28-4, lp36, cp32-6, cp32-7, lp5 and lp21, in addition to cp9. B) B31-A3 retains all twenty one plasmids
except cp9, as expected [22].
doi:10.1371/journal.pone.0004101.g003
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individually perfused intact venules
The effect of spent medium from cultured B31-A3 cells on
microvessel permeability was investigated in seven individual
venular microvessels. Fig. 4A shows a representative magnitude
and time course of Lp response to B31-A3 spent medium from one
of the vessels. The mean control Lp, measured with BSK-II
culture medium, was 1.160.3610
27 cm.s
21.cmH2O
21. Exposing
each vessel to B31-A3 spent medium caused a transient increase in
Lp. The mean peak Lp, occurring 2–5 min after the start of B31-
A3 spent medium perfusion, was 5.660.9 times that of the
medium control (Fig. 4D, N=7)
The effect of BSK-II medium on microvessel Lp was examined
in 4 additional venular microvessels. Fig. 4B shows the Lp
measurements from a single experiment. The mean control Lp of
4 vessels measured with albumin-Ringer perfusate was
1.860.3610
27 cm.sec
21.cmH2O
21. After each vessel was recan-
nulated and perfused with BSK-II medium, the mean Lp was
1.560.2610
27 cm.sec
21.cmH2O
21, which was not significantly
different from the Lp control level (Fig. 4D, N=4, P.0.05),
indicating that components in BSK-II medium had no effect on
basal Lp.
B31-A spent medium does not alter microvessel
permeability
The effect of B31-A spent medium on micovessel permeability
was investigated in 5 microvessels. The mean control Lp with
BSK-II medium perfusion was 2.260.6610
27 cm.s
21.cmH2O
21.
When each vessel was recannulated and perfused with B31-A
spent medium, Lp did not change (summarized in Fig. 4D, N=5,
P.0.05). In 3 of the 5 vessels, B31-A and B31-A3 spent medium
were applied to the same vessel sequentially. Perfusion of B31-A
spent medium did not increase Lp. Each vessel was then rinsed
with BSK-II medium and exposed to B31-A3 spent medium. A
significant increase in Lp was observed in each vessel, and the
mean peak Lp was 4.660.5 times that of control. Fig. 4C shows a
direct comparison of the effect of B31-A and B31-A3 spent
medium on Lp in the same vessel.
Figure 4. Effects of B31-A3, B31-A spent medium and BSK-II control medium on Lp. Relative changes in Lp are presented as Lptest/Lpcontrol.
Arrows indicate times at which perfusion with test solutions were initiated. A) One representative experiment showing a transient increase in Lp
induced by B31-A3 spent medium. B) A representative experiment showing Lp is unaffected when vessels were perfused with BSK-II medium. C) Time
course and magnitude changes in Lp from one representative paired experiment in which a venule was sequentially perfused with BSK-II medium,
B31-A spent medium, BSK-II medium, then B31-A3 spent medium. An increase in Lp was only seen upon perfusion with B31-A3 spent medium. D)
Summarized data of Lp changes induced by B31-A and B31-A3 spent medium; * indicates a significant increase (P,0.05) from negative control; {
indicates a significant decrease (P,0.05) from B31-A3 spent medium.
doi:10.1371/journal.pone.0004101.g004
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endothelial [Ca
2+]i
The effects of B31-A3 spent medium on endothelial [Ca
2+]i
were studied in 6 venules. A representative time course and
magnitude changes in endothelial [Ca
2+]i is shown in Fig. 5A. The
mean baseline [Ca
2+]i measured with albumin-Ringer perfusate
was 99612 nM (Fig. 5C, N=6). Each vessel was then recannu-
lated and perfused with BSK-II medium followed by perfusion
with B31-A3 spent medium. The mean endothelial [Ca
2+]i,
measured with BSK-II medium was 113611 nM, which was not
statistically different from the albumin-Ringer control (P.0.05). A
significant increase of endothelial [Ca
2+]i was observed when each
vessel was perfused with B31-A3 spent medium (Fig. 5A and
Fig. 5C, N=6). Endothelial [Ca
2+]i reached a mean peak value of
324635 nM in the first 2–3 minutes of B31-A3 spent medium
perfusion, and fell to a sustained level (160622 nM) after 10 min.
When each vessel was recannulated and perfused with albumin-
Ringer solution, [Ca
2+]i returned to the baseline level, 8664n M
(Fig. 5A).
B31-A spent medium does not alter endothelial [Ca
2+]i
The effects of B31-A and B31-A3 spent medium on endothelial
[Ca
2+]i were directly compared in four venules. A representative
change in magnitude and time course of endothelial [Ca
2+]i is
shown in Fig. 5B. The mean baseline [Ca
2+]i measured with
albumin-Ringer solution was 8364 nM. When each vessel was
recannulated and perfused with BSK-II medium the mean [Ca
2+]i
was 9168 nM, which was not significantly different from the
baseline (Figs. 5B and 5C, N=4, P.0.05). Perfusion of each vessel
with B31-A spent medium also did not induce a significant
increase in endothelial [Ca
2+]i, with a mean value of 127617 nM
(Fig. 5C, N=4, P.0.05). Each vessel was then perfused with B31-
A3 spent medium; the measured endothelial [Ca
2+]i reached a
mean peak value of 301615 nM within 3 min of B31-A3 spent
medium perfusion (Fig. 5B and Fig. 5C, N=4). These results show
that B31-A3 spent medium increased endothelial [Ca
2+]i, while
spent medium from B31-A did not have an effect.
Discussion
Our studies demonstrate for the first time that cell-free, spent
medium from virulent Bb induces a rapid and transient increase in
endothelial [Ca
2+]i and microvessel permeability (Lp) in rat
mesenteric venules in the absence of blood cells. The time course
and magnitude of increased Lp and [Ca
2+]i produced by Bb spent
medium are similar to those induced by direct-acting inflamma-
tory mediators, such as bradykinin or platelet activating factor
(PAF) [20,21]. This rapid and transient endothelial response to Bb
spent medium in intact microvessels is distinct from other reports
of Bb-mediated activation of cultured endothelial monolayers that
usually occurs hrs after incubation with Bb [4,5,19,31,32]. Because
the permeability effect of the spent medium was observed with
virulent Bb but not avirulent Bb, the production of this mediator
under culture conditions may be associated with Bb virulence, and
appears to be produced by one or more of the 8 plasmids missing
from our B31-A strain. We note that different plasmid contents
have been reported for strain B31-A. This report and others
[33,34] finds B31-A is missing lp21, lp25, lp28-1, lp28-4, lp-36,
cp9 and cp32-6. However, Lawrenz et al [33] report their B31-A
strain is also missing lp28-3, while our strain is also missing lp5 and
cp32-7 (apparently the other studies [33,34] did not examine the
presence of lp5). Thus B31-A is not a stable strain and it’s plasmid
content should be verified.
Figure 5. Effects of Bb spent medium on endothelial [Ca
2+]i. A) A
representative venule was sequentially perfused with 5% albumin-
Ringer (5% BSA Ringer), BSK-II medium, B31-A3 spent medium and 5%
albumin-Ringer, showing no endothelial [Ca
2+]i changes upon exposure
to BSK-II medium, while a transient increase in endothelial [Ca
2+]i was
observed within 2–3 min after exposure to B31-A3 spent medium. B)
Changes in endothelial [Ca
2+]i from one representative paired
experiment, showing no significant changes in endothelial [Ca
2+]i
during perfusion of B31-A spent medium, while a transient increase in
endothelial [Ca
2+]i occurred upon perfusion of B31-A3 spent medium.
Arrows indicate times at which perfusion with test solutions were
initiated. C) Summarized data for the effects of spent medium from B31-
A3 and B31-A on endothelial [Ca
2+]i; * indicates a significant increase
(P,0.05) from negative control; { indicates a significant decrease
(P,0.05) from B31-A3 spent medium.
doi:10.1371/journal.pone.0004101.g005
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lipoprotein to cultured endothelial monolayers induces endothelial
cells to produce proinflammatory cytokines, chemokines, adhesion
molecules and chemotaxis activity, promoting transendothelial
migration of lymphocytes and neutrophils [4,5,19,31,32]. Such
inflammatory reactions are dependent on endothelial or host cells
to produce inflammatory mediators and are only manifest after
hrs. Although incubating cultured endothelial cell monolayers with
Bb induced alterations of the endothelial barrier function,
measured by electric cell substrate impedance sensing, the barrier
function was not altered until five hr after addition of spirochetes
[6]. In contrast, the increases in microvessel Lp and [Ca
2+]i upon
addition of Bb spent medium peaked 2–5 min after the exposure
(Figs 4 and 5), and thus appear to be a direct effect of the Bb-
produced mediator under culture conditions.
Because the microvessel permeability effect was detected in cell-
free spent medium, this mediator may be secreted; alternatively, it
may be associated with membrane blebs that could pass through
0.1 mm filters [35], or be released by lysis of some cells during in
vitro growth, or due to consumption of a factor in BSK-II medium
by B31-A3 but not B31-A cells. While many pathogenic organisms
produce exotoxins, endotoxins or other virulence factors that may
directly induce inflammation, Bb is generally assumed not to
produce toxins or directly cause tissue damage [16,17,36]. Analysis
of the Bb genome indicated no classic toxins or virulence factors
were encoded on the chromosome or 21 plasmids that would
directly mediate inflammation [16,17]. Our results also show that
the transient increases in endothelial [Ca
2+]i and Lp induced by Bb
spent medium are distinct from the irreversible increases in
permeability induced by epsilon toxin, the direct-acting, primary
virulence factor for Clostridium perfringe [37]. Only 2–6% of the 670
potentially intact genes on all 21 plasmids were similar to
sequenced genes from other species with known and unknown
functions [16]. Therefore, the microvessel-inflammatory mediator
produced by Bb may be a novel type of inflammatory compound.
More importantly, this mediator may be associated with Bb
virulence and may be produced by one or more of the 8 plasmid(s)
missing from strain B31-A. However, it should be noted that a
chromosomal or plasmid mutation, independent of the 8 missing
plasmids, may also contribute to the lack of mediator production
by strain B31-A. Crude or undefined preparations, such as spent
medium used in this study, are often the initial source for detecting
a novel biological activity. Combined biochemical and genetic
approaches will be applied in future studies to identify and
characterize the source and chemical nature of this Bb-produced
permeability-increasing mediator.
The type of inflammation observed in our studies with Bb spent
medium could be difficult to detect in other systems, including
whole animal or cell culture systems. The individually perfused
microvessels have some unique advantages over other methodol-
ogies to detect the inflammatory mediator produced by Bb. First,
the effect of the spent medium was examined in intact microvessels
that have normal baseline permeability properties when experi-
ments are initiated. Second, the single vessel perfusion technique
allows microvessel permeability to be measured at a known
perfusion pressure and the surface area for water and solute
exchange can be measured precisely, which enables distinguishing
changes in microvessel permeability from variations of flow
dynamics and surface area under inflammatory conditions. Third,
the changes in permeability with Bb spent medium were compared
with its own control in the same vessel, which minimized the
variability between vessels and animals. Most importantly, Bb has
been reported to play significant roles in leukocyte adhesion and
migration initiated by host-derived proinflammatory cytokines or
chemokines [6,38]. Our experiments, conducted in the absence of
blood cells, enable the study of the direct effect of Bb-produced
mediator on the endothelium independent of any permeability
changes caused by leukocyte/endothelium interactions. The
immediate, transient increases in Lp observed with B31-A3 spent
medium perfusion indicate that Bb not only can induce the
expression of adhesion and proinflammatory molecules in
endothelia resulting in leukocyte adhesion and migration [6,38],
but may directly induce increases in microvessel permeability
through calcium-associated endothelial cell activation.
Previous studies demonstrated that inflammatory mediators
such as PAF, bradykinin, ATP, serotonin, and histamine, induce
transient increases in microvessel permeability [39–41], and most
of the permeability increases were initiated by increased
endothelial [Ca
2+]i via increased Ca
2+ influx [20,21,26,42]. Our
recent study further demonstrated that PAF-induced permeability
increases are the result of gap formation between endothelial cells,
which is critical for the subsequent formation and adhesion of
leukocyte/platelet aggregates [43,44]. The rapid induction of
microvessel permeability induced by Bb spent medium, and the
similarity in pattern to increased Lp and endothelial [Ca
2+]i
induced by direct-acting inflammatory compounds [20,21]
suggests the permeability increases caused by the Bb-produced
mediator may also be the result of endothelial gap formation. Our
culture conditions utilized much higher concentrations of Bb than
are encountered under physiological conditions. In Lyme disease
(lower Bb densities), changes in microvessel permeability may be
more subtle and may directly associate with the local adhesion and
penetration of Bb across microvessel walls. Recent studies by
Moriarty et. al. [45] and Norman et. al [46] demonstrated an in
vivo approach to visualize spirochete interactions with endothelial
cells and reported a fibronectin and sulfate-type glycosaminogly-
can-dependent adhesion process. Combining in vivo approaches
with fluorescence microscopy may allow further elucidation of
subtle and local changes in endothelial junctions and permeability
that may be associated with Bb adhesion and penetration
processes. Weakening endothelial cell-cell junctions may play an
essential role in Bb penetration into the vascular system for
dissemination or possibly to escape from the vasculature to
colonize susceptible tissues, including joints, the nervous system
and heart.
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